Cycad Group is a private equity general partner firm headquartered in Santa Barbara, CA, United States.
Biotech company Visterra has raised $30m in Series B funding from Vertex Venture Capital, Temasek, Polaris Partners and others.
Mérieux Développement, Novartis Venture, Cycad Group and Nextech have invested $21m in ImaginAb, a US-based clinical biotech company.
Vaccine developer Genocea Biosciences, backed by Polaris Venture Partners, Lux Capital Management and others has filed for an IPO.
Read more news concerning Cycad Group
A sampling of Cycad Group portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?